Imunon, Inc.: net property, plant and equipment
Imunon net property, plant and equipment: $529.9 thousand at 2025-12-31, down 2.1% on the year. 16 values since 2010 from SEC filings. In original units.
All Imunon, Inc. financial histories
At a glance
Imunon reported net property, plant and equipment of $529.9 thousand at 2025-12-31, down 2.1% from $541.3 thousand a year earlier. From 2010 to 2025 it grew at a compound 2.3% a year, from $378.7 thousand to $529.9 thousand. Across the last five reported years it ranged from $477.0 thousand (2021-12-31) to $751.9 thousand (2023-12-31). That was 4.3% of total assets ($12.3 million) at the same date.
Computed from the values in the table below, in USD; each links to the filing it came from.
What this measure means
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
Exact concept: us-gaap:PropertyPlantAndEquipmentNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2010-12-31 to 2025-12-31. The SEC response was captured on 2026-09-19.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| - | 2025-12-31 | 529,936 | USD | 2026-03-31 | 10-K · 0001493152-26-013850 SEC |
| - | 2024-12-31 | 541,272 | USD | 2026-03-31 | 10-K · 0001493152-26-013850 SEC |
| - | 2023-12-31 | 751,906 | USD | 2025-02-27 | 10-K · 0001493152-25-008460 SEC |
| - | 2022-12-31 | 548,301 | USD | 2024-03-28 | 10-K · 0001493152-24-011616 SEC |
| - | 2021-12-31 | 477,011 | USD | 2023-03-30 | 10-K · 0001493152-23-009604 SEC |
| - | 2020-12-31 | 294,551 | USD | 2022-03-31 | 10-K · 0001493152-22-008277 SEC |
| - | 2019-12-31 | 405,363 | USD | 2021-03-19 | 10-K · 0001493152-21-006382 SEC |
| - | 2018-12-31 | 184,627 | USD | 2020-03-25 | 10-K · 0001493152-20-004717 SEC |
| - | 2017-12-31 | 175,771 | USD | 2019-03-29 | 10-K · 0001493152-19-004184 SEC |
| - | 2016-12-31 | 462,836 | USD | 2018-03-27 | 10-K · 0001437749-18-005539 SEC |
| - | 2015-12-31 | 854,872 | USD | 2017-03-24 | 10-K · 0001437749-17-005235 SEC |
| - | 2014-12-31 | 1,170,497 | USD | 2016-03-30 | 10-K · 0001437749-16-028601 SEC |
| - | 2013-12-31 | 832,886 | USD | 2015-03-12 | 10-K · 0001437749-15-004805 SEC |
| - | 2012-12-31 | 1,114,621 | USD | 2014-03-13 | 10-K · 0001437749-14-004012 SEC |
| - | 2011-12-31 | 782,720 | USD | 2013-03-18 | 10-K · 0001437749-13-003088 SEC |
| - | 2010-12-31 | 378,672 | USD | 2012-03-15 | 10-K/A · 0001140361-12-015945 SEC |
Related Imunon, Inc. histories
Inspect the source
- Entity
- Imunon, Inc. / CIK 0000749647
- Captured
- SEC response SHA-256
cf2e46071525a607b4d539753f5129368297f1e667d6fa4f8829e76132e7a85a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
The MCP server is free and MIT-licensed: npx -y canli-mcp. If these records help your research, a star on GitHub helps other researchers find them.
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000749647.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))